1,755 filings
Page 19 of 88
6-K
16o7fv
30 Aug 16
Teva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International Congress
12:00am
6-K
z7jak
29 Aug 16
Live Filing
12:00am
6-K
xvsiwjrzrkz
25 Aug 16
Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE®40 mg
12:00am
6-K
89ohcxeiq8hp2ikz2y
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
SC 13D
uxj3a75bt
8 Aug 16
Teva Pharmaceutical Industries LTD
12:00am
6-K
5sa7wh kh21tnheg
5 Aug 16
Teva Announces Launch of Generic Gleevec® Tablets In the United States
12:00am
6-K
45x7f g2hgk2u371c
4 Aug 16
Teva Reports Second Quarter 2016 Results
12:00am
6-K
oobsrum11b2zsizw0
4 Aug 16
Current report (foreign)
12:00am
S-8
60dwg
3 Aug 16
Registration of securities for employees
12:00am
6-K
8hpyqx5z
3 Aug 16
Live Filing
12:00am
6-K
2ea1qp
2 Aug 16
Teva Completes Acquisition of Actavis Generics
12:00am
6-K
ovzahbahld94sc8g h0c
28 Jul 16
Current report (foreign)
12:00am
6-K
fuzmly7h4eo cyqw
27 Jul 16
Teva Receives Clearance from the U.s. Federal Trade Commission for Actavis Generics Acquisition
12:00am
6-K
0oh wryur
27 Jul 16
Live Filing
12:00am
6-K
j4xjbh674f jqn1s3we9
25 Jul 16
Current report (foreign)
12:00am
6-K
ovnfv6io0dl1tojv
21 Jul 16
Current report (foreign)
12:00am
6-K
bi8vat7
21 Jul 16
Current report (foreign)
12:00am
6-K
c0s7tzsgve 51uj249
20 Jul 16
Current report (foreign)
12:00am
FWP
yr3f4ujawtuo09y86i
19 Jul 16
Free writing prospectus
12:00am
424B5
wqgmvod
19 Jul 16
Prospectus supplement for primary offering
12:00am